305 related articles for article (PubMed ID: 20068089)
21. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma.
Alvaro T; Lejeune M; Camacho FI; Salvadó MT; Sánchez L; García JF; Lopez C; Jaén J; Bosch R; Pons LE; Bellas C; Piris MA
Haematologica; 2006 Dec; 91(12):1605-12. PubMed ID: 17145596
[TBL] [Abstract][Full Text] [Related]
22. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of PU.1 in follicular lymphoma.
Torlakovic EE; Bilalovic N; Golouh R; Zidar A; Angel S
J Pathol; 2006 Jul; 209(3):352-9. PubMed ID: 16639693
[TBL] [Abstract][Full Text] [Related]
24. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus.
Simpson N; Gatenby PA; Wilson A; Malik S; Fulcher DA; Tangye SG; Manku H; Vyse TJ; Roncador G; Huttley GA; Goodnow CC; Vinuesa CG; Cook MC
Arthritis Rheum; 2010 Jan; 62(1):234-44. PubMed ID: 20039395
[TBL] [Abstract][Full Text] [Related]
25. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.
Dave SS; Wright G; Tan B; Rosenwald A; Gascoyne RD; Chan WC; Fisher RI; Braziel RM; Rimsza LM; Grogan TM; Miller TP; LeBlanc M; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Connors JM; Lansdorp PM; Ouyang Q; Lister TA; Davies AJ; Norton AJ; Muller-Hermelink HK; Ott G; Campo E; Montserrat E; Wilson WH; Jaffe ES; Simon R; Yang L; Powell J; Zhao H; Goldschmidt N; Chiorazzi M; Staudt LM
N Engl J Med; 2004 Nov; 351(21):2159-69. PubMed ID: 15548776
[TBL] [Abstract][Full Text] [Related]
26. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.
Alvaro T; Lejeune M; Salvadó MT; Bosch R; García JF; Jaén J; Banham AH; Roncador G; Montalbán C; Piris MA
Clin Cancer Res; 2005 Feb; 11(4):1467-73. PubMed ID: 15746048
[TBL] [Abstract][Full Text] [Related]
27. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY
J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038
[TBL] [Abstract][Full Text] [Related]
28. Nodal follicular helper T-cell lymphoma may present with different patterns. A case report.
Qubaja M; Audouin J; Moulin JC; Molina TJ; Le Tourneau A; Gaulard P; Straub P; Audhuy B; Diebold J
Hum Pathol; 2009 Feb; 40(2):264-9. PubMed ID: 18760445
[TBL] [Abstract][Full Text] [Related]
29. Predicting outcome in follicular lymphoma by using interactive gene pairs.
LeBrun D; Baetz T; Foster C; Farmer P; Sidhu R; Guo H; Harrison K; Somogyi R; Greller LD; Feilotter H
Clin Cancer Res; 2008 Jan; 14(2):478-87. PubMed ID: 18223222
[TBL] [Abstract][Full Text] [Related]
30. [Two-color flow cytometry analysis of lymphocyte subsets in patients with acute myocardial infarction and post-myocardial infarction syndrome].
Tsuchihashi M; Sakaguchi Y; Nakamura M; Sutani T; Tsuruta S; Kato S; Uemura S; Nishida Y; Hashimoto T; Kagoshima T
J Cardiol; 1995 Aug; 26(2):69-79. PubMed ID: 7674146
[TBL] [Abstract][Full Text] [Related]
31. Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma.
Tzankov A; Matter MS; Dirnhofer S
Pathobiology; 2010; 77(6):301-8. PubMed ID: 21266828
[TBL] [Abstract][Full Text] [Related]
32. The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma.
Hasselblom S; Sigurdadottir M; Hansson U; Nilsson-Ehle H; Ridell B; Andersson PO
Br J Haematol; 2007 May; 137(4):364-73. PubMed ID: 17456059
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype.
Weng WK; Czerwinski D; Timmerman J; Hsu FJ; Levy R
J Clin Oncol; 2004 Dec; 22(23):4717-24. PubMed ID: 15483014
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
[TBL] [Abstract][Full Text] [Related]
35. Helper T cells (CD3 + /CD4 + ) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients.
Schmidmaier R; Oversohl N; Schnabel B; Straka C; Emmerich B
Exp Oncol; 2008 Sep; 30(3):240-3. PubMed ID: 18806749
[TBL] [Abstract][Full Text] [Related]
36. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
[TBL] [Abstract][Full Text] [Related]
37. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.
Canioni D; Salles G; Mounier N; Brousse N; Keuppens M; Morchhauser F; Lamy T; Sonet A; Rousselet MC; Foussard C; Xerri L
J Clin Oncol; 2008 Jan; 26(3):440-6. PubMed ID: 18086798
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
[TBL] [Abstract][Full Text] [Related]
39. T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab.
Wahlin BE; Sundström C; Holte H; Hagberg H; Erlanson M; Nilsson-Ehle H; Lindén O; Nordström M; Ostenstad B; Geisler CH; Brown Pde N; Lehtinen T; Maisenhölder M; Tierens AM; Sander B; Christensson B; Kimby E
Clin Cancer Res; 2011 Jun; 17(12):4136-44. PubMed ID: 21518780
[TBL] [Abstract][Full Text] [Related]
40. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
Baadsgaard O; Fox DA; Cooper KD
J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
